Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
International Journal of Biological Macromolecules
|
July 5, 2025
Quercetin infused starch matrix as a sustainable approach to smart packaging: A comprehensive review
Zaryab Shafi, Rahul Singh, Urba Shafiq Sidiqi, et al.
International Journal of Molecular Sciences
|
May 7, 2025
New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies
Megan Reidy, Meerah Khan, Elizabeth A Mills, et al.
Biorxiv : the Preprint Server for Biology
|
January 18, 2024
Immune-responsive gene-1: The mitochondrial Key to Th17 Cell Pathogenicity in CNS Autoimmunity
Mohammad Nematullah, Mena Fatma, Guoli Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 4, 2025
Immune-responsive gene 1: The mitochondrial key to Th17 cell pathogenicity in CNS autoimmunity
Mohammad Nematullah, Mena Fatma, Guoli Zhou, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients
Insha Zahoor, Jeffrey Waters, Nasar Ata, et al.
Iscience
|
October 16, 2023
An early glycolysis burst in microglia regulates mitochondrial dysfunction in oligodendrocytes under neuroinflammation
Hamid Suhail, Mohammad Nematullah, Faraz Rashid, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 14, 2022
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
Insha Zahoor, Hamid Suhail, Indrani Datta, et al.
The Journal of Biological Chemistry
|
January 26, 2025
Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
International Journal of Biological Macromolecules
|
July 5, 2025
Quercetin infused starch matrix as a sustainable approach to smart packaging: A comprehensive review
Zaryab Shafi, Rahul Singh, Urba Shafiq Sidiqi, et al.
International Journal of Molecular Sciences
|
May 7, 2025
New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies
Megan Reidy, Meerah Khan, Elizabeth A Mills, et al.
Biorxiv : the Preprint Server for Biology
|
January 18, 2024
Immune-responsive gene-1: The mitochondrial Key to Th17 Cell Pathogenicity in CNS Autoimmunity
Mohammad Nematullah, Mena Fatma, Guoli Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 4, 2025
Immune-responsive gene 1: The mitochondrial key to Th17 cell pathogenicity in CNS autoimmunity
Mohammad Nematullah, Mena Fatma, Guoli Zhou, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients
Insha Zahoor, Jeffrey Waters, Nasar Ata, et al.
Iscience
|
October 16, 2023
An early glycolysis burst in microglia regulates mitochondrial dysfunction in oligodendrocytes under neuroinflammation
Hamid Suhail, Mohammad Nematullah, Faraz Rashid, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 14, 2022
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
Insha Zahoor, Hamid Suhail, Indrani Datta, et al.
The Journal of Biological Chemistry
|
January 26, 2025
Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Page
of 3